Instituto Nacional de Enfermedades Neoplásicas

Recent papers from Instituto Nacional de Enfermedades Neoplásicas

1. Incremental value of TAPSE added to HFA-ICOS for ESC-Defined Cancer Therapy–Related Cardiac DysfunctionEuropean Heart Journal · 2026
2. Cardio-oncology infrastructure, training, and practice patterns in latin america: a multinational survey of 74 institutionsEuropean Heart Journal · 2026
3. Enforcement activity or administrative visibility? Decomposing two decades of labour inspection fines in Peru, 2002–2023Social Sciences & Humanities Open · 2026
4. Predictors of Early Mortality After Induction Chemotherapy in Acute Myeloid Leukemia: Experience from a Latin American Cancer CenterInternational Journal of Cancer Care and Delivery · 2026
5. Breast cancer protective genetic variant common in women of Indigenous American genetic ancestry is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-enriched tumor subtypesCancer Research Communications · 2026
6. Intraoperative or postoperative radiotherapy boost in high-risk breast cancer: a matched-pair analysisStrahlentherapie und Onkologie · 2026
7. 8th International consensus guidelines for the management of advanced breast cancer (ABC8 guidelines)The Breast · 2026
8. Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysisHaematologica · 2026
9. Pembrolizumab Plus Chemotherapy for Cervical CancerJAMA Oncology · 2026
10. Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA StudyClinical Cancer Research · 2026
11. Clinical Characteristics and Outcomes of Melanoma Among Latin American Adolescents and Young Adults Compared to Middle-Aged and Elderly Population: A Cohort Analysis Over 10 YearsJournal of Adolescent and Young Adult Oncology · 2026
12. Preferences for Neurotization of Functioning Free Muscle Transplantation in Long-Standing Facial Paralysis – Global Insights from 107 ExpertsPlastic & Reconstructive Surgery · 2026
13. Global Disparities in Melanoma Incidence, Mortality, and Mortality-to-Incidence Ratio: An Analytical Framework Using the Human Development IndexJCO Global Oncology · 2026
14. Long-term safety of first-line osimertinib plus platinum–pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2Lung Cancer · 2026
15. Sociodemographic and Clinicopathologic Characteristics of Patients With Invasive Breast Cancer in Latin America: The LATINA Breast Cohort (LACOG 0615/MO39485)JCO Global Oncology · 2026
16. Trop-2 overexpression as a prognostic marker in early triple-negative breast cancer: results from the GEICAM_CIBOMA trialBreast Cancer Research · 2026
17. CA 15.3, Metastatic Burden, and Overall Survival in Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer: Real-World Evidence from PeruBiomedicines · 2026
18. Conditional Associations Among Chronic Disease Indicators, Risk Behaviors, Health Habits, and Disability Indicators in an Analytic ENDES Sample of Peruvian Adults: A Secondary Analysis Using Exploratory Network Analysis, 2021–2023Lifestyle Medicine · 2026
19. Communication quality shapes the sustainability of pediatric early warning systemBMC Health Services Research · 2026
20. Fungal diagnostics and antifungal drug access in Latin America and the Caribbean: an ESCMID EFISG multinational surveyNature Communications · 2026